FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents a preparation for involving a mesenchymal stem cell of the bone marrow into peripheral blood from the bone marrow, which is introduced into the blood vessel or muscle and which contains any of components: (a) protein HMGB1; (b) HMGB1 protein-secreting cell; (c) a vector, into which HMGB1 protein-coding DNA is inserted; (d) protein HMGB2; (e) HMGB2 protein-secreting cell; (f) a vector, into which HMGB2 protein-coding DNA is inserted; (g) protein HMGB3; (h) HMGB3 protein-secreting cell; and (i) a vector, into which HMGB3 protein-coding DNA is inserted.
EFFECT: elaboration of the preparation for involving the mesenchymal stem cell of the bone marrow into peripheral blood from the bone marrow.
3 cl, 6 ex, 1 tbl, 14 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR HIGH-EFFICIENCY COLLECTION OF FUNCTIONAL CELLS IN VIVO | 2009 |
|
RU2571230C2 |
TISSUE-REGENERATION PROMOTER USING RECRUITMENT OF BONE MARROW MESENCHYMAL STEM CELLS AND/OR PLURIPOTENT STEM CELLS IN BLOOD | 2010 |
|
RU2599448C2 |
NOVEL METHOD FOR TREATING SPINAL CORD INJURY USING HMGB1 FRAGMENT | 2013 |
|
RU2649069C2 |
NEW METHOD OF TREATMENT OF MYOCARDIAL INFARCTION WITH APPLICATION OF FRAGMENT HMGB1 | 2013 |
|
RU2647467C2 |
THERAPEUTIC AGENT FOR THE TREATMENT OF CARDIOMYOPATHY, PREVIOUS MYOCARDIAL INFARCTION AND CHRONIC HEART FAILURE | 2018 |
|
RU2795320C2 |
ENGINEERED MESENCHYMAL STEM CELLS AND METHOD FOR USING THEM FOR TREATING TUMOURS | 2010 |
|
RU2539099C2 |
HUMANISED MOUSE M-CSF | 2012 |
|
RU2577978C2 |
HUMANIZED M-CSF MICE | 2020 |
|
RU2819731C2 |
METHOD OF PRODUCING RECOMBINANT PROTEIN TAT-HOXB4H FOR USE AS HEMOPOIESIS STIMULATOR IN VIVO | 2008 |
|
RU2401863C2 |
POLYPEPTIDE-LIGAND FLT3 (VARIANTS), POLYNUCLEOTIDE (VARIANTS), EXPRESSING VECTOR (VARIANTS), STRAIN OF CELL CHO (VARIANTS), METHOD FOR PRODUCING POLYPEPTIDE-LIGAND FLT3 (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) | 1994 |
|
RU2220979C2 |
Authors
Dates
2014-06-20—Published
2009-04-30—Filed